DH ENCHANTMENT, INC., a company primarily engaged in the sale and distribution of COVID-19 rapid antigen tester sets through its Hong Kong subsidiary, Ho Shun Yi Limited, has released its Form 10-Q report for the third quarter of 2023. The report highlights significant financial and operational challenges faced by the company, including a notable decline in revenue and ongoing net losses.
Financial Highlights
- Revenue: The company generated revenues of $686,000 for the six months ended September 30, 2023, compared to $6,581,000 for the same period in 2022, indicating a significant decrease.
- Gross Profit (Loss): The report indicates a gross loss due to certain inventory items being sold at or below cost because of close expiration dates.
- Operating Income (Loss): The company reported a loss from operations of $37,329,000 for the six months ended September 30, 2023, compared to a loss of $281,384,000 for the same period in 2022.
- Net Income (Loss): The net loss for the six months ended September 30, 2023 was $42,786,000 compared to a net loss of $273,026,000 for the same period in 2022.
- Net Loss Per Share: The net loss per share remained at less than $0.001 for both basic and diluted shares for the six months ended September 30, 2023 and 2022.
Business Highlights
- Revenue Segments: The company generates revenue primarily from the sale and distribution of COVID-19 rapid antigen tester sets through its Hong Kong subsidiary, Ho Shun Yi Limited. The revenue for the three months ended September 30, 2023, was significantly lower compared to the same period in 2022, indicating a decline in demand or sales volume.
- Geographical Performance: All of the company's customers are located in Hong Kong, which suggests a concentrated market presence. This geographical focus may expose the company to regional economic and political risks.
- Sales Units: The company sold certain inventory items at cost due to close expiration dates, which impacted the cost of revenue and resulted in a gross loss for the six months ended September 30, 2023.
- Future Outlook: The company is facing substantial doubt about its ability to continue as a going concern due to ongoing net losses and a working capital deficit. Management is focused on improving profitability and securing financial support from stockholders to sustain operations.
SEC Filing: